While there’s been some exciting research into the therapeutic potential of cannabinoids, we’ve yet to fully realize the potential of these natural compounds on health and healing.
Documented use of cannabinoids as a therapeutic agent dates back to 2,700 BC.
Research into the benefits of cannabinoids has faced adversity and has been prevented from making significant breakthroughs. At one point, cannabinoids were recognized for their medical properties and considered a common component in the country’s pharmacological industry. Despite protests by the American Medical Association, Congress passed a law to federally restrict the distribution of cannabinoids in 1937. In 1970, cannabis and some cannabinoids were classified as Schedule I substances under the Controlled Substances Act. This legal status remains in effect today and hinders clinical research. Because of how cannabis is restricted under the Controlled Substances Act, researchers must get through complex regulations before they can proceed. They need to obtain registration from the US Drug Enforcement Administration and have the study further approved by the Food and Drug Administration. Once they get all the proper approvals, researchers are forced to obtain all of their cannabinoid materials from the National Institute on drug Abuse, which grows limited varieties on a single plot of land at the University of Mississippi. The institute can refuse to provide researchers if they determine the study lacking in scientific value. According to Popular Science, the institute has repeatedly declined to work with researchers looking to prove the effectiveness of cannabinoids for conditions or symptoms. Despite the many challenges, medical research has revealed the potential and promise of cannabinoids. For anyone suffering from pain, epilepsy, arthritis, anxiety, multiple sclerosis, Alzheimer’s disease, Parkinson’s disease and a long list of symptoms and conditions, there is hope for better quality of life.